{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:33:29Z","timestamp":1791380009078,"version":"4.3.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T00:00:00Z","timestamp":1692057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T00:00:00Z","timestamp":1692057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The incidence of cervical cancer in Uyghur women ranks first among those in Han and other ethnic minority groups. We aimed to understand the natural history of HPV in Uyghur women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A\u00a0longitudinal cohort study on the natural history of HPV infection in rural Uyghur women in China was conducted between May 2013 and May 2014. A total of 11000 women from South Xinjiang underwent HPV screening by careHPV and liquid-based cytology.\u00a0Ultimately, a total of 298 women with positive HPV and normal biopsy results or CIN1 were enrolled to participate in a study including follow-up HPV testing for two years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The HPV infection rate in Uyghur women was 9.15%. Among the participants, the careHPV test showed that 298\u00a0women were HPV-positive, and histology showed CIN1 or normal results for these women at baseline. Among these patients, after 24\u00a0months of initial recruitment, 92\u00a0(30.87%) patients had persistent HPV infections, and 206\u00a0(69.13%) had cleared HPV infection. Univariate analysis showed that persistent HPV infection was associated with age and shower frequency (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001\u00a0and\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.047, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results suggest that women over the age of 50\u00a0years who have been infected with HR-HPV for more than 1\u00a0year should be regularly screened and monitored for HPV. In addition, education should be strengthened to improve poor health habits in these women.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12905-023-02558-y","type":"journal-article","created":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T04:01:46Z","timestamp":1692072106000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Prevalence, persistence, clearance and risk factors for HPV infection in rural Uyghur women in China"],"prefix":"10.1186","volume":"23","author":[{"given":"Gulixian","family":"Tuerxun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guligeina","family":"Abudurexiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guzalinuer","family":"Abulizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,15]]},"reference":[{"key":"2558_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nrclinonc.2015.146","volume":"13","author":"X Bosch","year":"2016","unstructured":"Bosch X, Robles F, Diaz C, Arbyn M, Baussano M, et al. HPV-FASTER: broadening the scope for prevention of HPV related cancer. Nat Rev Clin Oncol. 2016;13:119\u201332.","journal-title":"Nat Rev Clin Oncol"},{"key":"2558_CR2","first-page":"15","volume":"10","author":"AC Bharti","year":"2018","unstructured":"Bharti AC, Singh T, Bhat A, Pande D, Jadli M. Therapeutic startegies for human papillomavirus infection and associated cancers. FrontBiosci. 2018;10:15\u201373.","journal-title":"FrontBiosci"},{"key":"2558_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"WQ Chen","year":"2016","unstructured":"Chen WQ, Zheng RS, Baade PD, Zhang SW, Zeng HM, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115\u201332.","journal-title":"CA Cancer J Clin"},{"key":"2558_CR4","first-page":"764","volume":"38","author":"YH Peng","year":"2003","unstructured":"Peng YH, Lalei S, Zhou K, Wang ZH, Fang XZ, et al. Clinical analysis of cervical cancer cases. Chinese J Obstet Gynecol. 2003;38:764\u20135.","journal-title":"Chinese J Obstet Gynecol"},{"key":"2558_CR5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12905-019-0785-3","volume":"19","author":"J Wang","year":"2019","unstructured":"Wang J, Tang DD, Wang K, Wang JL, Zhang ZX, et al. HPV genotype prevalence and distribution during 2009\u20132018 in Xinjiang, China: baseline surveys prior to mass HPV vaccination. BMC Womens Health. 2019;19:90.","journal-title":"BMC Womens Health"},{"key":"2558_CR6","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S1470-2045(08)70210-9","volume":"9","author":"YL Qiao","year":"2008","unstructured":"Qiao YL, Sellors JW, Eder PS, Bao YP, Lim JM, et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol. 2008;9:929\u201336.","journal-title":"Lancet Oncol."},{"key":"2558_CR7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12879-018-3105-x","volume":"18","author":"PS Zhao","year":"2018","unstructured":"Zhao PS, Liu SD, Zhong ZX, Hou JY, Lin LF, et al. Prevalence and genotype distribution of humanpapillomavirus infection among women in northeastern Guangdong Province of China. BMC Infect Dis. 2018;18:204.","journal-title":"BMC Infect Dis"},{"key":"2558_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/LGT.0000000000000243","volume":"20","author":"SS Xiao","year":"2016","unstructured":"Xiao SS, Fan JL, He SL, Li YR, Wang LY, et al. Analysis of human papillomavirus infection in 16,320 patients from a gynecology clinic in central South China. J Low Genit Tract Dis. 2016;20:327\u201331.","journal-title":"J Low Genit Tract Dis"},{"key":"2558_CR9","doi-asserted-by":"publisher","first-page":"21039","DOI":"10.1038\/srep21039","volume":"6","author":"Z Li","year":"2016","unstructured":"Li Z, Liu F, Cheng S, Shi L, Yan ZL, et al. Prevalence of HPV infection among 28,457 Chinese women in Yunnan Province, southwest China. Sci Rep. 2016;6:21039.","journal-title":"Sci Rep"},{"key":"2558_CR10","first-page":"1026","volume":"41","author":"S Sui","year":"2014","unstructured":"Sui S, Niyaz M, Zhu KC, Wang L, Lu P, et al. Significance of human papilloma virus subtype detection in oppor-tunistic screening for cervical cancer in Uygur and Han women. Chin J Clin Oncol. 2014;41:1026\u201330.","journal-title":"Chin J Clin Oncol"},{"key":"2558_CR11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1093\/jnci\/92.6.464","volume":"92","author":"R Herrero","year":"2000","unstructured":"Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, et al. Population-based study ofhuman papillomavirus infection and cervical neoplasia in rural CostaRica. J Natl Cancer Inst. 2000;92:464\u201374.","journal-title":"J Natl Cancer Inst"},{"key":"2558_CR12","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/s12879-016-1782-x","volume":"16","author":"SE Rudolph","year":"2016","unstructured":"Rudolph SE, Lorincz A, Wheeler CM, Gravitt P, Ponce EL, et al. Population-based prevalence of cervical infection with human papillomavirus genotypes 16 and 18 and other high risk types in Tlaxcala. Mexico BMC Infect Dis. 2016;16:461.","journal-title":"Mexico BMC Infect Dis"},{"key":"2558_CR13","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1002\/jmv.24748","volume":"89","author":"D Cao","year":"2017","unstructured":"Cao D, Zhang SH, Zhang Q, Wei X, Zhao MY, et al. Prevalence of high-risk human papillomavirus infection among women in Shaanxi province of China: a hospital-based investigation. J Med Virol. 2017;89:1281\u20136.","journal-title":"J Med Virol"},{"key":"2558_CR14","doi-asserted-by":"publisher","first-page":"497","DOI":"10.4049\/jimmunol.167.1.497","volume":"167","author":"SJ Lee","year":"2001","unstructured":"Lee SJ, Cho YS, Cho MC, Shim JH, Lee KA, et al. Both E6 and E7 oncoproteins of humanpapillomavirus16inhibit IL-1 8induced IFN-gamma production in human peripheral bloodmononuclear and NK cells. J Immunol. 2001;167:497\u2013504.","journal-title":"J Immunol"},{"key":"2558_CR15","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S0140-6736(02)08151-5","volume":"359","author":"N Mu\u00f1oz","year":"2002","unstructured":"Mu\u00f1oz N, Franceschi S, Bosetti C, Moreno V, Herrero R, et al. International agency for research on cancer. multicentriccervical cancer study group. role of parity and humanpapillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet. 2002;359:1093\u2013101.","journal-title":"Lancet"},{"key":"2558_CR16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ijid.2016.04.004","volume":"46","author":"FS Alhamlan","year":"2016","unstructured":"Alhamlan FS, Khayat HH, Ramisetty MS, Al-Muammar TA, Tulbah AM, et al. Sociodemographiccharacteristics and sexual behavior as risk factors for humanpapillomavirus infection in Saudi Arabia. Int J Infect Dis. 2016;46:94\u20139.","journal-title":"Int J Infect Dis."},{"key":"2558_CR17","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1097\/AOG.0000000000000760","volume":"125","author":"JP Lekovich","year":"2015","unstructured":"Lekovich JP, Amrane S, Pangasa M, Pereira N, Frey MK, et al. Comparison of HumanPapillomavirus infection and cervical cytology in women usingcopper-containing levonorgestrel-containing intrauterine devices. Obstet Gynecol. 2015;125:1101\u20135.","journal-title":"Obstet Gynecol"},{"key":"2558_CR18","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1470-2045(11)70223-6","volume":"12","author":"X Castellsagu\u00e9","year":"2011","unstructured":"Castellsagu\u00e9 X, Diaz M, Vaccarella S, Sanjos\u00e9 SD, Mu\u00f1oz N, et al. Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies. Lancet Oncol. 2011;12:1023\u201331.","journal-title":"Lancet Oncol"},{"key":"2558_CR19","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/ijc.27828","volume":"133","author":"AF Rositch","year":"2013","unstructured":"Rositch AF, Koshiol J, Hudgens MG, Razzaghi H, Backes DM, et al. Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis. Int J Cancer. 2013;133:1271\u201385.","journal-title":"Int J Cancer"},{"key":"2558_CR20","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1097\/AOG.0b013e318277c92a","volume":"120","author":"Committee on Practice Bulletins\u2014Gynecology","year":"2012","unstructured":"Committee on Practice Bulletins\u2014Gynecology. ACOG practice bulletin number 131: Screening for cervical cancer. Obstet Gynecol. 2012;120:1222\u201338.","journal-title":"Obstet Gynecol"},{"key":"2558_CR21","first-page":"766","volume":"39","author":"YR Zhang","year":"2018","unstructured":"Zhang YR, Huang WH, Jing LP, Jing CX. Influencing factors of persistent infection in some Area of Guangdong Province. J Sun Yat\u2043Sen University(Medical Sciences). 2018;39:766\u201370.","journal-title":"J Sun Yat\u2043Sen University(Medical Sciences)"},{"key":"2558_CR22","first-page":"534","volume":"37","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Cao D, Ma Q, Li N, Cui XQ, et al. Natural outcome of genital tract high risk human papillomavirus infection and associated factors among 760 women. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2015;37:534\u201340.","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"2558_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s12879-016-1633-9","volume":"16","author":"S Taylor","year":"2016","unstructured":"Taylor S, Bunge E, Bakker M, Castellsagu\u00e9 X. The incidence, clearance and persistence of non-cervical human papillomavirus infections: a systematic review of the literature. BMC Infect Dis. 2016;16:293.","journal-title":"BMC Infect Dis"},{"key":"2558_CR24","first-page":"408","volume":"24","author":"A Guzalnur","year":"2004","unstructured":"Guzalnur A, Peng ZL, Liu SL, Wang H. The difference of expression of HPV and its subtypes among women from Northwest Sichuan and southern Xinjiang. Chin J Microbiol Immunol. 2004;24:408.","journal-title":"Chin J Microbiol Immunol"},{"key":"2558_CR25","doi-asserted-by":"publisher","first-page":"e011371","DOI":"10.1136\/bmjopen-2016-011371","volume":"6","author":"AV Ramanakumar","year":"2016","unstructured":"Ramanakumar AV, Naud P, Roteli-Martins CM, Carvalho NS, Borba PC, et al. Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-na\u00efve women: results from the control arm of a phase II HPV-16\/18 vaccine trial. BMJ Open. 2016;6:e011371.","journal-title":"BMJ Open"},{"key":"2558_CR26","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1097\/OLQ.0000000000001053","volume":"46","author":"M El-Zein","year":"2019","unstructured":"El-Zein M, Ramanakumar AV, Naud P, Roteli-Martins CM, Carvalho NS, et al. Determinants of acquisition and clearance of human papillomavirus infection in previously unexposed young womem. Sex Transm Dis. 2019;46:663\u20139.","journal-title":"Sex Transm Dis"},{"key":"2558_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jcv.2016.07.020","volume":"83","author":"PV Weele","year":"2016","unstructured":"Weele PV, Logchem EV, Wolffs P, Broek IV, Feltkamp M, et al. Correlation between viral load, multiplicity of infection and persistence of infection in a Dutch cohort of young women. J clin Virol. 2016;83:6\u201311.","journal-title":"J clin Virol"},{"key":"2558_CR28","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/ijc.27986","volume":"133","author":"CE Schmeink","year":"2013","unstructured":"Schmeink CE, Massuger LFAG, Lenselink CH, QuintW GV, Witte BI, et al. Prospective follow-up of 2,065 young unscreened women to study human papillomavirus incidence and clearance. Int J Cancer. 2013;133:172\u201381.","journal-title":"Int J Cancer"},{"key":"2558_CR29","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ejogrb.2013.01.012","volume":"168","author":"ML Sammarco","year":"2013","unstructured":"Sammarco ML, Riccio ID, Tamburro M, Grasso GM, Ripabelli G. Type-specific persistence and associated risk factors of human papillomavirus infections inwomen living in central Italy. Eur J Obs Gynecol. 2013;168:222\u20136.","journal-title":"Eur J Obs Gynecol"},{"key":"2558_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ijgo.2004.07.013","volume":"87","author":"EM Smith","year":"2004","unstructured":"Smith EM, Johnson SR, Ritchie JM, Feddersen D, Wang D, et al. Persistent HPV infection in postmenopausal age women. Int J Gynaecol Obstet. 2004;87:131\u20137.","journal-title":"Int J Gynaecol Obstet"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02558-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-023-02558-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02558-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T19:07:02Z","timestamp":1700334422000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-023-02558-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,15]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2558"],"URL":"https:\/\/doi.org\/10.1186\/s12905-023-02558-y","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,15]]},"assertion":[{"value":"19 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research ethics committee of the Affiliated Tumor Hospital of Xinjiang Medical University approved the research program (G-201250). Each participant signed an informed consent form. For participants who were illiterate, informed consent was obtained from a parent or legal guardian.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"433"}}